# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA802833 | F | Cytotoxicity against human stomach cancer cell line SNU-16 in MTT assay | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
2. | ALA802834 | F | In vitro cytotoxicity activity against human stomach cancer cell lines SNU-16 | Homo sapiens | 35 | cell-based format | Scientific Literature | ||
3. | ALA802839 | F | In vitro cytotoxicity against SNU16 tumor cell lines. | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
4. | ALA984399 | F | Cytotoxicity against human SNU16 cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 12 | cell-based format | Scientific Literature | ||
5. | ALA2363554 | F | SANGER: Inhibition of human NCI-SNU-16 cell growth in a cell viability assay. | Homo sapiens | 77 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
6. | ALA5256650 | F | Cytotoxicity against human SNU-16 cells assessed as inhibition of cell growth measured after 72 hrs by cell titer glo assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
7. | ALA5256666 | F | Antitumor activity against human SNU-16 cells xenografted in mouse cells at lowest dose administered orally and measured upto 15 days | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
8. | ALA3420528 | F | Selectivity index, ratio of IC50 for human SNU16 cells to IC50 for human MKN45 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
9. | ALA3420535 | F | Selectivity index, ratio of IC50 for human SNU16 cells to IC50 for human EBC1 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
10. | ALA3420542 | F | Selectivity index, ratio of IC50 for human SNU16 cells to IC50 for human SNU5 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
11. | ALA3998339 | F | Antiproliferative activity against human SNU16 cells after 72 hrs by CCK8 assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
12. | ALA4002777 | F | Antiproliferative activity against FGFR2-amplified human SNU16 cells after 72 hrs by CCK8/SRB assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
13. | ALA4002792 | F | Antitumor activity against FGFR2-amplified human SNU16 cells xenografted in nude mouse assessed as tumor growth inhibition at 20 mg/kg, po qd administered for 18 days and measured on day 18 post last dose relative to vehicle-treated control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
14. | ALA4002800 | F | Antitumor activity against FGFR2-amplified human SNU16 cells xenografted in nude mouse assessed as tumor growth inhibition at 30 mg/kg, po qd administered for 18 days and measured on day 18 post last dose relative to vehicle-treated control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
15. | ALA4013830 | F | Antiproliferative activity against human SNU16 cells over-expressing FGFR2 after 72 hrs by Presto-Blue assay | Homo sapiens | 26 | cell-based format | Scientific Literature | ||
16. | ALA4013906 | F | Antitumor activity against human SNU16 cells xenografted in nude mouse assessed as tumor growth inhibition administered po bid for 27 days measured 3 times weekly during compound dosing | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
17. | ALA4013907 | F | Antitumor activity against human SNU16 cells xenografted in nude mouse assessed as tumor growth inhibition at 0.625 mg/kg, po bid for 27 days measured 3 times weekly during compound dosing relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
18. | ALA4013908 | F | Antitumor activity against human SNU16 cells xenografted in nude mouse assessed as tumor growth inhibition at 1.25 mg/kg, po bid for 27 days measured 3 times weekly during compound dosing relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
19. | ALA4013909 | F | Antitumor activity against human SNU16 cells xenografted in nude mouse assessed as tumor growth inhibition at 2.5 mg/kg, po bid for 27 days measured 3 times weekly during compound dosing relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
20. | ALA4013910 | F | Antitumor activity against human SNU16 cells xenografted in nude mouse assessed as tumor growth inhibition at 10 mg/kg, po bid for 27 days measured 3 times weekly during compound dosing relative to control | Homo sapiens | 1 | organism-based format | Scientific Literature |